Literature DB >> 25028224

Prevalence of chronic obstructive pulmonary disease in Saudi Arabia.

Siraj O Wali1, Majdy M Idrees, Omer S Alamoudi, Ahmed M Aboulfarag, Abdelrahman D Salem, Ahmed A Aljohaney, Mohamed H Soliman, Muntasir M Abdelaziz.   

Abstract

OBJECTIVE: To assess the prevalence of epidemiologically defined chronic obstructive pulmonary disease (COPD) in Saudi Arabia.
METHODS: This cross-sectional, observational, population-based survey of COPD was conducted between June 2010 and December 2011 across the country of Saudi Arabia. A total of 56,000 randomly selected telephone numbers were called, which identified 10,001 eligible subjects; of whom 9,779 agreed to participate. A screening questionnaire included 6 questions related to cigarette consumption and water-pipe use was administered to each participant. Subjects with positive screening results were invited to provide input for a detailed COPD questionnaire.
RESULTS: The adjusted proportion of subjects who reported a current, or past smoking history was 27.9%. Gender specific smoking rates adjusted by age were 38.7% (95% confidence interval [CI]: 37.5-39.9%) in men, and 7.4% (95% CI: 6.5-8.3%) in women. The epidemiological definition of symptomatic COPD was met by a total of 249 subjects. The age and gender-adjusted prevalence of COPD was 2.4% (95% CI: 2.1-2.7%). Overall, COPD was more frequently documented (p<0.0001) in men (3.5% [95% CI: 3-4%]) than in women (1% [95% CI: 0.7-1.3%]).
CONCLUSION: The prevalence of epidemiologically defined COPD in the general population of Saudi Arabia is 2.4%, which is lower than that reported in industrialized countries.

Entities:  

Mesh:

Year:  2014        PMID: 25028224

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  8 in total

1.  Prevalence of Electronic Cigarette Use in Saudi Arabia.

Authors:  Nawaf K Althobaiti; Mohammad Eid M Mahfouz
Journal:  Cureus       Date:  2022-06-07

2.  The existence of bronchiectasis predicts worse prognosis in patients with COPD.

Authors:  Bei Mao; Hai-Wen Lu; Man-Hui Li; Li-Chao Fan; Jia-Wei Yang; Xia-Yi Miao; Jin-Fu Xu
Journal:  Sci Rep       Date:  2015-06-16       Impact factor: 4.379

3.  Factors influencing management of chronic respiratory diseases in general and chronic obstructive pulmonary disease in particular in Saudi Arabia: An overview.

Authors:  Mohammed E Alsubaiei; Paul A Cafarella; Peter A Frith; R Doug McEvoy; Tanja W Effing
Journal:  Ann Thorac Med       Date:  2018 Jul-Sep       Impact factor: 2.219

4.  Characteristics and related factors of bronchiectasis in chronic obstructive pulmonary disease.

Authors:  Qihong Yu; Haiying Peng; Bo Li; Hongyu Qian; Hong Zhang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

5.  A needs-based methodology to project physicians and nurses to 2030: the case of the Kingdom of Saudi Arabia.

Authors:  Samantha Gailey; Tim A Bruckner; Tracy Kuo Lin; Jenny X Liu; Mohammed Alluhidan; Taghred Alghaith; Hussah Alghodaier; Nabiha Tashkandi; Christopher H Herbst; Mariam M Hamza; Nahar Alazemi
Journal:  Hum Resour Health       Date:  2021-04-26

6.  Risk factors for bronchiectasis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  XinXin Zhang; LiJian Pang; XiaoDong Lv; HaoYang Zhang
Journal:  Clinics (Sao Paulo)       Date:  2021-04-16       Impact factor: 2.365

7.  Prevalence of restless legs syndrome and associated risk factors among middle-aged Saudi population.

Authors:  Siraj Omar Wali; Bahaa Abaalkhail
Journal:  Ann Thorac Med       Date:  2015 Jul-Sep       Impact factor: 2.219

8.  A cross-sectional observational study to assess inhaler technique in Saudi hospitalized patients with asthma and chronic obstructive pulmonary disease.

Authors:  Maha Al Ammari; Khizra Sultana; Faisal Yunus; Mohammed Al Ghobain; Shatha M Al Halwan
Journal:  Saudi Med J       Date:  2016-05       Impact factor: 1.484

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.